TLSA
Tiziana Life Sciences Ltd
1.10$
-0.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 28.2% | 10.0% | 58.0% | 42.8% | 26.4% | 44.7% | 46.7% | 36.5% | 27.6% | 32.8% | 11.2% | 9.6% | 18.1% | 73.9% | 28.1% | 100.0% | 100.0% | 100.0% | 99.4% | 99.0% | 99.9% | 63.3% | 99.3% | 99.7% | 91.7% | 60.2% | 66.5% | 74.4% | |
| 21.1% | 6.7% | 48.4% | 33.1% | 0.3% | 30.1% | 18.6% | 27.3% | 16.1% | 20.3% | 1.3% | 1.7% | 6.9% | 5.3% | 4.2% | 48.4% | 92.1% | 96.2% | 93.1% | 2.6% | 76.6% | 8.5% | 93.2% | 86.4% | 68.4% | 9.7% | 33.0% | 34.9% | |
| 21.1% | 6.7% | 52.8% | 33.1% | 21.2% | 30.1% | 18.6% | 27.3% | 16.1% | 20.3% | 1.3% | 1.7% | 6.9% | 72.8% | 20.8% | 60.3% | 92.1% | 96.2% | 93.1% | 2.6% | 76.6% | 8.5% | 93.2% | 86.4% | 68.4% | 9.7% | 33.0% | 34.9% | |
| – | – | – | – | – | – | 25.8% | 5.0% | 8.4% | 9.0% | 4.4% | 3.0% | 7.6% | – | – | – | 4.1% | 2.9% | 1.9% | 84.6% | 18.7% | 71.1% | 5.4% | 10.8% | 22.1% | 49.7% | 32.7% | 37.0% | |
| – | – | – | – | – | – | 0.0% | 0.1% | 0.6% | 0.2% | 1.5% | 2.2% | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -71.4% | 0.0% | -10.9% | -22.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.6% | 1.3% | 0.1% | 24.3% | 0.5% | 0.0% | 1.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 48.7% | – | 47.6% | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | -0.1% | – | – | – | – | – | |
| 71.7% | 89.8% | 40.4% | 56.0% | 72.6% | 55.2% | 52.8% | 62.9% | 71.6% | 67.1% | 40.1% | 90.4% | 41.8% | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.2% | 0.3% | – | – | – | – | |
| 15.7% | 15.6% | 11.0% | 10.9% | 14.0% | 8.5% | 14.5% | 17.9% | 23.2% | 15.9% | 32.4% | 29.9% | 40.8% | 16.0% | 141.7% | 215.9% | 27.8% | 8.1% | 34.4% | 191.9% | 92.5% | 331.2% | 11.7% | 15.5% | 26.1% | 54.6% | 65.1% | 99.5% | |
| 15.7% | 15.6% | 11.0% | 10.9% | 14.0% | 8.5% | 14.5% | 17.9% | 20.0% | 12.5% | 27.3% | 24.1% | 40.8% | 16.0% | 141.7% | 215.9% | 27.8% | 8.1% | 34.4% | 191.9% | 97.6% | 308.5% | 11.3% | 15.5% | 25.2% | 53.7% | 65.1% | 97.5% | |
| – | – | – | – | 2.7% | – | 2.4% | 2.2% | 2.3% | 1.8% | 2.6% | 2.8% | – | – | – | 182.5% | 8.4% | 2.3% | 4.5% | 12.8% | 4.5% | 48.6% | 3.3% | 2.8% | 0.5% | 1.1% | 0.9% | 1.9% | |
| 14.2% | 14.9% | 3.9% | 5.4% | 6.9% | 4.3% | 10.2% | 12.3% | 17.9% | 14.6% | 30.4% | 28.9% | 54.8% | 14.1% | 129.2% | 19.8% | 2.6% | 3.4% | 24.0% | 151.2% | 55.6% | 224.2% | 4.8% | 9.0% | 18.7% | 34.0% | 49.5% | 62.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 84.4% | 84.5% | 89.0% | 89.1% | 86.0% | 91.5% | 85.5% | 82.1% | 76.8% | 84.1% | 67.6% | 70.1% | 59.2% | 84.0% | -41.7% | -115.9% | 72.2% | 91.9% | 65.6% | -91.9% | 7.5% | -231.2% | 64.7% | 84.5% | 73.9% | 45.4% | 34.9% | 0.5% | |
| -10.2% | -35.1% | -78.5% | -176.1% | -318.3% | -306.0% | -277.8% | -396.5% | -500.7% | -624.4% | -993.3% | -1,179.7% | -2,089.2% | -3,278.4% | -22,024.0% | -17,004.8% | -145.8% | -132.3% | 218.5% | -1,625.1% | -731.6% | -2,386.4% | -119.8% | -221.3% | -439.1% | -1,097.1% | -1,283.5% | -386.4% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.2% | 0.4% | 0.6% | 1.7% | 6.0% | 34.3% | 104.9% | 949.3% | 9,074.0% | 232.4% | 505.9% | 1,053.3% | 3,194.4% | 987.9% | 3,774.4% | 68.9% | 100.3% | 191.7% | 416.6% | 472.7% | 514.5% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.